Recombinant multi-species NME7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NME7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the non-metastatic expressed family of nucleoside diphosphate kinases. Members of this family are enzymes that catalyzes phosphate transfer from nucleoside triphosphates to nucleoside diphosphates. This protein contains two kinase domains, one of which is involved in autophosphorylation and the other may be inactive. This protein localizes to the centrosome and functions as a component of the gamma-tubulin ring complex which plays a role in microtubule organization. Mutations in this gene may be associated with venous thromboembolism. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
The Alternative Names of target: 3'-5' exonuclease NME7,CFAP67,D530024H21Rik,MN23H7,NDK 7,NDK7,NDP kinase homolog 7,NME7,Nm23-M7,Nm23-r7,Nme7,Nucleoside diphosphate kinase homolog 7,Protein kinase NME7,nm23-H7

Target products collectionGo to NME7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7858-Ag-1/ GM-Tg-hg-IP7858-Ag-2 Human NME7 protein Human
GM-Tg-rg-IP7858-Ag-1/ GM-Tg-rg-IP7858-Ag-2 Rat NME7 protein Rat
GM-Tg-mg-IP7858-Ag-1/ GM-Tg-mg-IP7858-Ag-2 Mouse NME7 protein Mouse
GM-Tg-cynog-IP7858-Ag-1/ GM-Tg-cynog-IP7858-Ag-2 Cynomolgus/Rhesus macaque NME7 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7858-Ag-1/ GM-Tg-felg-IP7858-Ag-2 Feline NME7 protein Feline
GM-Tg-cang-IP7858-Ag-1/ GM-Tg-cang-IP7858-Ag-2 Canine NME7 protein Canine
GM-Tg-bovg-IP7858-Ag-1/ GM-Tg-bovg-IP7858-Ag-2 Bovine NME7 protein Bovine
GM-Tg-equg-IP7858-Ag-1/ GM-Tg-equg-IP7858-Ag-2 Equine NME7 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7858-Ag-1/ GM-Tg-hg-IP7858-Ag-2; GM-Tg-rg-IP7858-Ag-1/ GM-Tg-rg-IP7858-Ag-2;
GM-Tg-mg-IP7858-Ag-1/ GM-Tg-mg-IP7858-Ag-2; GM-Tg-cynog-IP7858-Ag-1/ GM-Tg-cynog-IP7858-Ag-2;
GM-Tg-felg-IP7858-Ag-1/ GM-Tg-felg-IP7858-Ag-2; GM-Tg-cang-IP7858-Ag-1/ GM-Tg-cang-IP7858-Ag-2;
GM-Tg-bovg-IP7858-Ag-1/ GM-Tg-bovg-IP7858-Ag-2; GM-Tg-equg-IP7858-Ag-1/ GM-Tg-equg-IP7858-Ag-2
Products Name NME7 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NME7
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NME7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.